Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HighCycle Study: Acetazolamide for Sleep Disordered Breathing at High Altitude
NCT06498531Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Jul 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetazolamide in sleep disordered breathing (SDB) (4 arms), sponsored by University of Zurich. Primary endpoint: Nocturnal Oxygen Desaturation Index. Started Jul 2024; status: completed.
02
Drugs
acetazolamide
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT06498531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06498531.